Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2197870A Co-administered with Prevenar in Healthy Infants
NCT00871338Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2009
- Primary completion
- Mar 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GSK2197870A in meningococcal infection, Haemophilus influenzae type b infection (Hib), diphtheria, Tetanus, pertussis, sponsored by GSK. Started Jun 2009; status: completed.
02
Drugs
GSK2197870A
03
Conditions
meningococcal infectionHaemophilus influenzae type b infection (Hib)diphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT00871338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00871338.